Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease

35Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Monoamine oxidase (MAO) is an enzyme regulating metabolism of neurotransmitters such as dopamine. Two distinct forms of enzyme, encoded by genes MAOA and MAOB located on the X chromosome, have been considered as possible factors in the pathogenesis of Parkinson disease (PD). Previous association studies of PD and MAO genes reported inconsistent results. In this study, we used a large family-based data set to test associations between MAO genes and a risk of PD. The data set includes 298 female discordant sibpairs and 348 male discordant sibpairs. For this study, all subjects analyzed were white and families with known parkin mutations were removed. We analyzed 15 single nucleotide polyrnorphisms (SNPs) and a dinucleotide repeat marker in the MAO genes. Association was found with the intron 13 SNP of MAOB in the female subset (P = 0.02). No significant association was found in the male subset. Our results add to the evidence of involvement of MAOB in PD and suggest that the effect may be stronger in women. © 2006 Movement Disorder Society.

Author supplied keywords

Cite

CITATION STYLE

APA

Kang, S. J., Scott, W. K., Li, Y. J., Hause, M. A., van der Walt, J. M., Fujiwara, K., … Martin, E. R. (2006). Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. Movement Disorders, 21(12), 2175–2180. https://doi.org/10.1002/mds.21151

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free